Filter

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 1 of 1 items for

  • Author: Marie Louise Muff Wissing x
Clear All Modify Search
Pernille Bækgaard Udesen The Fertility Clinic, Department of Gynecology and Obstetrics, Zealand University Hospital, Køge, Denmark
Department of Science and Environment, Roskilde University, Roskilde, Denmark

Search for other papers by Pernille Bækgaard Udesen in
Google Scholar
PubMed Close
,
Dorte Glintborg Department of Endocrinology and Metabolism, Odense University Hospital, Odense, Denmark

Search for other papers by Dorte Glintborg in
Google Scholar
PubMed Close
,
Anja Elaine Sørensen Department of Science and Environment, Roskilde University, Roskilde, Denmark

Search for other papers by Anja Elaine Sørensen in
Google Scholar
PubMed Close
,
Rikke Svendsen Department of Science and Environment, Roskilde University, Roskilde, Denmark

Search for other papers by Rikke Svendsen in
Google Scholar
PubMed Close
,
Nanna Louise Skov Nielsen Department of Science and Environment, Roskilde University, Roskilde, Denmark
Department of Clinical Immunology, Næstved Hospital, Næstved, Denmark

Search for other papers by Nanna Louise Skov Nielsen in
Google Scholar
PubMed Close
,
Marie Louise Muff Wissing Aleris Hamlet Hospital Group, The Fertility Clinic, Søborg, Denmark

Search for other papers by Marie Louise Muff Wissing in
Google Scholar
PubMed Close
,
Marianne Skovsager Andersen Department of Endocrinology and Metabolism, Odense University Hospital, Odense, Denmark

Search for other papers by Marianne Skovsager Andersen in
Google Scholar
PubMed Close
,
Anne Lis Mikkelsen Englund The Fertility Clinic, Department of Gynecology and Obstetrics, Zealand University Hospital, Køge, Denmark

Search for other papers by Anne Lis Mikkelsen Englund in
Google Scholar
PubMed Close
, and
Louise Torp Dalgaard Department of Science and Environment, Roskilde University, Roskilde, Denmark

Search for other papers by Louise Torp Dalgaard in
Google Scholar
PubMed Close

Metformin is associated with increased insulin sensitivity, whereas oral contraceptive pills (OCP) could increase the risk for type 2 diabetes (T2D) in women with polycystic ovary syndrome (PCOS). Certain miRNAs might serve as biomarkers for the risk of T2D. The aim of this study was to investigate changes in circulating miRNA levels during treatment with metformin and OCP in women with PCOS. Sixty-five women with PCOS according to Rotterdam criteria were randomized to metformin (2 g/day), metformin + OCP (150 mg desogestrel + 30 µg ethinylestradiol) or OCP alone for 12 months. Serum miRNA analysis was performed with individual RT-qPCR or Taqman low density array cards of 22 selected miRNAs previously related to PCOS, glucose and/or lipid metabolism. miR-122 and miR-29a levels were decreased after treatment with metformin compared with metformin + OCP and OCP group: miR-122: log2 difference −0.7 (P = 0.01) and −0.7 (P = 0.02), miR-29a: log2 difference −0.5 (P = 0.01) and −0.4 (P = 0.04), while miR-223 levels were decreased in the metformin + OCP group after treatment: log2 difference −0.5 (P = 0.02). During the treatment period, a significant weight loss was observed in the metformin group compared with the OCP group. In the OCP group, miRNA levels were unchanged during the treatment period. Levels of circulating miRNAs associated with lipid and glucose metabolism decreased during metformin treatment. Changes in miRNA levels in the metformin group could be explained by the simultaneous weight loss in the same group. These results support the notion that metformin treatment alone may be superior for metabolic health compared with OCP.

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-20-0195
Volume/Issue:
Volume 9: Issue 11
Open access